PMA P160037S021

Device
Onclarity HPV Assay
Applicant
Becton, Dickinson and Company
PMA number
P160037
Supplement
S021
Product code
MAQ
Decision date
2025-03-12
Classification
Microbiology
Generic name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Approval order statement
Approval of the SHIP-Sub-Protocol LMI-001-A-S01_Version 3.0 for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P160037-S017.

Current openFDA PMA Record#

Device
Onclarity HPV Assay
Applicant
Becton, Dickinson and Company
PMA number
P160037
Supplement
S021
Product code
MAQ
Generic name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Decision date
2025-03-12
Decision code
APPR
Date received
2025-02-11
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
Approval of the SHIP-Sub-Protocol LMI-001-A-S01_Version 3.0 for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P160037-S017.